Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
14 hedge funds and large institutions have $262K invested in Aoxing Pharmaceutical Company Inc. in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
40% more funds holding
Funds holding: 10 → 14 (+4)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
93% less capital invested
Capital invested by funds: $3.53M → $262K (-$3.26M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$65.6K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$49.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$40.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$21.7K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$12.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.16M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.5K |
| 3 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$7.69K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.71K |
| 5 |
CK
Carnick & Kubik
Colorado Springs,
Colorado
|
-$222 |
AXN Hedge Fund Activity: Q4 2015 in Review
14 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q4 2015, worth a combined $262K — down 93% from $3.53M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new AXN positions and 3 closed out — a net gain of 4 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $65.6K. The largest seller was Sabby Management, exiting entirely with an estimated $3.16M sold.
- 14 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q4 2015, up from 10 in Q3 2015.
- Funds reported $262K of Aoxing Pharmaceutical Company Inc. stock for Q4 2015, down 93% quarter-over-quarter.
- 7 funds opened new Aoxing Pharmaceutical Company Inc. positions in Q4 2015 and 3 closed out, a net change of +4 holders.
- The largest Aoxing Pharmaceutical Company Inc. buyer in Q4 2015 was Bank of New York Mellon, an estimated $65.6K added.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q4 2015 was Sabby Management, an estimated $3.16M sold.
Based on aggregated 13F filings for Q4 2015.